JOURNAL ARTICLE
RESEARCH SUPPORT, NON-U.S. GOV'T
Add like
Add dislike
Add to saved papers

Calcium antagonists retard extracellular matrix production in connective tissue equivalent.

Hypertrophic and keloid scars are characterized by the overproduction of extracellular matrix collagen and proteoglycans. Because cellular secretion of macromolecules is known to be a calcium-dependent process, we have examined the effect of calcium antagonists on the rate of incorporation of [3H]proline into protein and Na235SO4 into sulfated glycosaminoglycans. Experiments were carried out in vitro using uniaxially oriented mammalian fibroblast-populated collagen matrices which exhibit many histoarchitectural features of scar matrix. We observed that nifedipine and verapamil in sufficient concentrations inhibited the incorporation of proline into extracellular matrix protein. The concentration range studied was 1 to 100 microM. Cobalt chloride (200 microM) had a similar effect on proline incorporation, but enhanced the incorporation of sulfate into extracellular matrix glycosaminoglycans. We conclude that cellular calcium metabolism appears to regulate extracellular matrix production and that hypertrophic disorders of wound healing may respond to therapy with calcium antagonist drugs.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app